AU2022299196A1 - Method to control administration of active substance to the digestive tract - Google Patents
Method to control administration of active substance to the digestive tract Download PDFInfo
- Publication number
- AU2022299196A1 AU2022299196A1 AU2022299196A AU2022299196A AU2022299196A1 AU 2022299196 A1 AU2022299196 A1 AU 2022299196A1 AU 2022299196 A AU2022299196 A AU 2022299196A AU 2022299196 A AU2022299196 A AU 2022299196A AU 2022299196 A1 AU2022299196 A1 AU 2022299196A1
- Authority
- AU
- Australia
- Prior art keywords
- active substance
- digestive tract
- control administration
- administration
- control
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163214438P | 2021-06-24 | 2021-06-24 | |
| US63/214,438 | 2021-06-24 | ||
| PCT/US2022/034683 WO2022271922A1 (en) | 2021-06-24 | 2022-06-23 | Method to control administration of active substance to the digestive tract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2022299196A1 true AU2022299196A1 (en) | 2023-12-21 |
Family
ID=84544830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022299196A Pending AU2022299196A1 (en) | 2021-06-24 | 2022-06-23 | Method to control administration of active substance to the digestive tract |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240285699A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4340819A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024526149A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117479929A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022299196A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023027371A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3223905A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022271922A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116270523B (zh) * | 2023-05-15 | 2023-08-08 | 四川厌氧生物科技有限责任公司 | 一种耐酸的口服双层胶囊及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2667167C (en) * | 2006-10-27 | 2014-02-18 | Pfizer Products Inc. | Hydroxypropyl methyl cellulose hard capsules and process of manufacture |
| BR112012006651B1 (pt) * | 2009-09-24 | 2021-11-03 | Capsugel Belgium Nv | Cápsula farmacêutica dura resistente a ácido e composição aquosa compreendendo goma de gelano e hpmc |
| DE102010022174A1 (de) * | 2010-05-12 | 2011-11-17 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh | Neue Darreichungsformen für Cineol |
| US9907755B2 (en) * | 2013-03-14 | 2018-03-06 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
| EP3028694B1 (en) * | 2014-12-02 | 2017-07-12 | Capsugel Belgium NV | Dosage form articles for delayed release |
| EP3882259B1 (en) * | 2015-05-13 | 2026-01-28 | Synlogic Operating Company, Inc. | Bacteria engineered to reduce hyperphenylalaninemia |
| EP4480495A3 (en) * | 2017-07-10 | 2025-06-18 | Gel Cap Technologies, LLC | Dual release dosage form capsule and methods, devices and systems for making same |
| US20190388344A1 (en) * | 2018-06-22 | 2019-12-26 | Probiotech Llc | Method to Improve The Health Of The Microbiome In A Human Gastrointestinal System and Multi-Chamber Probiotic Delivery Products Therefor |
| US20200038215A1 (en) * | 2018-08-01 | 2020-02-06 | Ethicon, Inc. | Transient implantable device to control absorption of nutrients |
| US12144834B2 (en) * | 2018-09-13 | 2024-11-19 | Xbiome Inc. | Methods and compositions for treating gastrointestinal and inflammatory disorders |
| CA3117956A1 (en) * | 2018-10-30 | 2020-05-07 | Vitabolus Inc. | Oral delivery of therapeutic mammalian cells |
| MX2022004515A (es) * | 2019-10-16 | 2022-07-12 | Capsugel Belgium Nv | Metodo y composicion para aumentar la sintesis de proteinas musculares. |
-
2022
- 2022-06-23 US US18/572,983 patent/US20240285699A1/en active Pending
- 2022-06-23 CN CN202280041826.5A patent/CN117479929A/zh active Pending
- 2022-06-23 CA CA3223905A patent/CA3223905A1/en active Pending
- 2022-06-23 WO PCT/US2022/034683 patent/WO2022271922A1/en not_active Ceased
- 2022-06-23 AU AU2022299196A patent/AU2022299196A1/en active Pending
- 2022-06-23 BR BR112023027371A patent/BR112023027371A2/pt unknown
- 2022-06-23 EP EP22829292.6A patent/EP4340819A4/en active Pending
- 2022-06-23 JP JP2023578776A patent/JP2024526149A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3223905A1 (en) | 2022-12-29 |
| BR112023027371A2 (pt) | 2024-03-12 |
| JP2024526149A (ja) | 2024-07-17 |
| CN117479929A (zh) | 2024-01-30 |
| EP4340819A4 (en) | 2025-04-02 |
| WO2022271922A1 (en) | 2022-12-29 |
| EP4340819A1 (en) | 2024-03-27 |
| US20240285699A1 (en) | 2024-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2011112229A3 (en) | Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device | |
| WO2017171535A3 (en) | Compositions | |
| EP4327797A3 (en) | Multi phase soft gel capsules, apparatus and method thereof | |
| AU2016219653A1 (en) | Crystallization Method and Bioavailability | |
| WO2011127302A3 (en) | Vehicle for delivering a compound to a mucous membrane and related compositions, methods and systems | |
| WO2011149877A8 (en) | Intestinal brake inducing intraluminal therapeutic substance eluting devices and methods | |
| PL3793534T3 (pl) | Tabletka doustna do dostarczania składników czynnych do przewodu żołądkowo-jelitowego | |
| WO2011152809A3 (en) | Effervescent formulations comprising cephalosporin and clavulanic acid | |
| EP4133990A4 (en) | METHOD AND SYSTEM FOR CONTROLLING A CAPSULE ENDOSCOPE | |
| UA96794C2 (ru) | Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе | |
| HK1255584A1 (zh) | 使用阿坎酸及d-环丝胺酸的联合疗法 | |
| EP4363444A4 (en) | ADMINISTRATION OF ANTI-HPA-1A ANTIBODIES | |
| EP3873538A4 (en) | ORAL DELIVERY OF THERAPEUTIC MAMMALIAN CELLS | |
| WO2011093818A3 (en) | Pharmaceutical compositions comprising salmeterol and fluticasone | |
| WO2007147043A3 (en) | Pharmaceutical formulations for iontophoretic tetracycline antibiotic delivery | |
| TW200602090A (en) | Antibiotic-based pharmaceutical formulation in microcapsular form | |
| WO2012063005A3 (fr) | Composition pharmaceutique et forme galenique a base de dronedarone et son procede de preparation | |
| EP4297741A4 (en) | METHODS AND FORMULATIONS FOR TOPICAL ADMINISTRATION OF GABAPENTINOIDS | |
| PT3768244T (pt) | Formulação de libertação instestinal de uma enzima digestiva, método de preparação e preparação galénica | |
| BR112023027371A2 (pt) | Método para controlar administração de substância ativa ao trato digestivo | |
| WO2011093811A3 (en) | Pharmaceutical preparations comprising formoterol and fluticasone | |
| WO2007062335A8 (en) | New pleuromutilin derivative and its use | |
| HK40112715A (en) | Dosage form for improving palatability of drug substance | |
| HK40111254A (en) | Administration of c5-binding proteins | |
| HK40116574A (en) | Transdermal therapeutic system for the transdermal administration of selexipag |